摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(二氟甲氧基)苯乙酸 | 86867-68-7

中文名称
2-(二氟甲氧基)苯乙酸
中文别名
——
英文名称
2-(difluoromethoxy)phenylacetic acid
英文别名
2-[2-(difluoromethoxy)phenyl]acetic acid
2-(二氟甲氧基)苯乙酸化学式
CAS
86867-68-7
化学式
C9H8F2O3
mdl
MFCD00236237
分子量
202.158
InChiKey
HQSIEUGDICOLBI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    286.0±35.0 °C(Predicted)
  • 密度:
    1.328±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    14
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.222
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    5

安全信息

  • 海关编码:
    2918990090

SDS

SDS:4e8ed3d775f18fe488627b402c91d138
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-(Difluoromethoxy)phenylacetic acid
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-(Difluoromethoxy)phenylacetic acid
CAS number: 86867-68-7

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H8F2O3
Molecular weight: 202.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(二氟甲氧基)苯乙酸草酰氯N,N-二甲基甲酰胺 作用下, 以 二氯甲烷 为溶剂, 反应 3.0h, 以100%的产率得到[2-(Difluoromethoxy)phenyl]acetyl chloride
    参考文献:
    名称:
    [EN] FUSED [1,2,4]THIADIAZINE DERIVATIVES WHICH ACT AS KAT INHIBITORS OF THE MYST FAMILY
    [FR] DÉRIVÉS DE [1,2,4]THIADIAZINE FUSIONNÉS AGISSANT EN TANT QU'INHIBITEURS DE KAT DE LA FAMILLE DES MYST
    摘要:
    一种化合物的化学式(I):抑制MYST家族中一个或多个KATs的活性,即TIP60、KAT6B、MOZ、HBO1和MOF。
    公开号:
    WO2019043139A1
点击查看最新优质反应信息

文献信息

  • [EN] TRIAZOLOPYRIDAZINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY<br/>[FR] DÉRIVÉS DE TRIAZOLOPYRIDAZINE À TITRE DE MODULATEURS DE L'ACTIVITÉ DU TNF
    申请人:UCB BIOPHARMA SPRL
    公开号:WO2015086511A1
    公开(公告)日:2015-06-18
    A series of substituted [1,2,4]triazolo[4,3-b]pyridazine derivatives of formula (I), being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
    一系列替代的[1,2,4]三唑并[4,3-b]吡啶嗪衍生物,化学式为(I),是人类TNFα活性的有效调节剂,因此在治疗和/或预防各种人类疾病方面具有益处,包括自身免疫和炎症性疾病;神经学和神经退行性疾病;疼痛和伤害感知性疾病;心血管疾病;代谢性疾病;眼科疾病;以及肿瘤学疾病。
  • [EN] TRIAZOLOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY<br/>[FR] DÉRIVÉS DE TRIAZOLOPYRIDINE COMME MODULATEURS DE L'ACTIVITÉ DU TNF
    申请人:UCB BIOPHARMA SPRL
    公开号:WO2015086496A1
    公开(公告)日:2015-06-18
    A series of substituted [l,2,4]triazolo[4,3-α]pyridine derivatives, being potent modulators of human TNFα activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
    一系列替代的[l,2,4]三唑并[4,3-α]吡啶衍生物,作为有效的人类TNFα活性调节剂,因此在治疗和/或预防各种人类疾病方面具有益处,包括自身免疫和炎症性疾病;神经和神经退行性疾病;疼痛和伤害感知性疾病;心血管疾病;代谢性疾病;眼部疾病;以及肿瘤性疾病。
  • [EN] AROMATIC SULFONAMIDE DERIVATIVES<br/>[FR] DÉRIVÉS DE SULFONAMIDE AROMATIQUE
    申请人:BAYER PHARMA AG
    公开号:WO2016198374A1
    公开(公告)日:2016-12-15
    Substituted aromatic sulfonamides of formula (I) pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease.
    公式(I)的取代芳香磺胺类化合物,包括所述化合物的药物组合物和组合物,以及利用所述化合物制造用于治疗或预防疾病的药物组合物。
  • MULTI-CYCLIC COMPOUNDS
    申请人:KIMURA Teiji
    公开号:US20090062529A1
    公开(公告)日:2009-03-05
    A compound represented by the formula (I): or a pharmacologically acceptable salt thereof, wherein Ar 1 represents an imidazolyl group or the like which may be substituted with a C1-6 alkyl group, Ar 2 represents a phenyl group or the like which may be substituted with a C1-6 alkoxy group, X 1 represents a double bond or the like and Het represents a triazolyl group or the like which may be substituted with a C1-6 alkyl group or the like, is effective as a therapeutic or prophylactic agent for a disease caused by Aβ.
    一种由化学式(I)表示的化合物或其药理学可接受的盐,其中Ar1代表可用C1-6烷基基团取代的咪唑基团或类似基团,Ar2代表可用C1-6烷氧基团取代的苯基团或类似基团,X1代表双键或类似基团,Het代表可用C1-6烷基基团或类似基团取代的三唑基团或类似基团,对由Aβ引起的疾病具有治疗或预防作用。
  • [EN] FIELD OF APPLICATION OF THE INVENTION<br/>[FR] SULFAMOYLBENZAMIDES
    申请人:BAYER PHARMA AG
    公开号:WO2018104305A1
    公开(公告)日:2018-06-14
    Substituted aromatic sulfonamides of formula (I) which are antagonists or negative allosteric modulators of P2X4, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease.
    式(I)的取代芳香磺胺类化合物,其为P2X4的拮抗剂或负向变构调节剂,包括所述化合物的药物组合物和药物组合物的使用,用于制造用于治疗或预防疾病的药物组合物。
查看更多